2022
DOI: 10.1177/0271678x221126280
|View full text |Cite
|
Sign up to set email alerts
|

Phenotypic variability in 446 CADASIL patients: Impact of NOTCH3 gene mutation location in addition to the effects of age, sex and vascular risk factors

Abstract: The recent discovery that the prevalence of cysteine mutations in the NOTCH3 gene responsible for CADASIL was more than 100 times higher in the general population than that estimated in patients highlighted that the mutation location in EGFr-like-domains of the NOTCH3 receptor could have a major effect on the phenotype of the disease. The exact impact of such mutations locations on the multiple facets of the disease has not been fully evaluated. We aimed to describe the phenotypic spectrum of a large populatio… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

1
14
1

Year Published

2023
2023
2024
2024

Publication Types

Select...
8

Relationship

2
6

Authors

Journals

citations
Cited by 20 publications
(16 citation statements)
references
References 68 publications
1
14
1
Order By: Relevance
“…We observed a similar point prevalence of ICH to that previously reported from European CADASIL cohorts, which ranged from 0.5% to 2.7% [ 42 44 ]; however, ICH was more commonly observed in the Asian cohorts. A recent meta-analysis reported the pooled prevalence of ICH in CADASIL of 10.1%, with 17.7% and 2.0% within the Asian and European subgroups, respectively [ 45 47 ].…”
Section: Discussionsupporting
confidence: 88%
“…We observed a similar point prevalence of ICH to that previously reported from European CADASIL cohorts, which ranged from 0.5% to 2.7% [ 42 44 ]; however, ICH was more commonly observed in the Asian cohorts. A recent meta-analysis reported the pooled prevalence of ICH in CADASIL of 10.1%, with 17.7% and 2.0% within the Asian and European subgroups, respectively [ 45 47 ].…”
Section: Discussionsupporting
confidence: 88%
“…5 Similarly, modifiable vascular risk factors such as hypertension and hypercholesterinemia were associated with stroke penetrance in a French CADASIL study. 20 To date, no randomized controlled trials have been conducted to examine whether reducing cardiovascular risk can effectively mitigate the risk of stroke in individuals with NOTCH3 variants.…”
Section: Discussionmentioning
confidence: 99%
“…Data obtained in patients and controls were compared after adjustment for age and sex. Association between clinical or imaging parameters and each retinal vascular parameter was assessed by multivariable analyses using generalised linear models and adjustment for age, presence of hypertension (HT), presence of other vascular risk factors, location of mutation in EGFR domains of the Notch3 protein, from 1 to 6 vs 7 to 34, which has been shown to influence the severity of the CADASIL phenotype 7 8…”
Section: Methodsmentioning
confidence: 99%